BridgeMD
New treatment option for Ischemic Stroke
Official title Empowerment and Mobile Technology in the Control of Cardiovascular Risk Factors in Patients With Ischemic Stroke
ClinicalTrials.gov ID: NCT03710902
What this study is testing
- What it's testing
- The CARDIOSTROKE is a randomized trial comparing mobile-device assisted control of hypertension together with screening of occult atrial fibrillation to standard care in patients with recent ischemic stroke or transient ischemic attack.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 and older
You may be able to join if
- Ischemic stroke or transient ischemic attack (ABCD2 score ≥3)
- Age ≥40 years
- Pre-existing or newly diagnosed hypertension
- Informed consent from the patient or legal representative
You likely can't join if
- Known high-risk source of cardioembolism
- Known indication for anticoagulation
- Contraindication for anticoagulation
- Pacemaker
- Non-compliance to study interventions as judged by the investigator
- Serious condition hampering the study conduct
The study team makes the final eligibility decision.
Where it's taking place
- Hämeenlinna, Finland
- Helsinki, Finland
- Hyvinkää, Finland
- Lahti, Finland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hämeenlinna, Finland; Helsinki, Finland; Hyvinkää, Finland; Lahti, Finland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.